CalciMedica (CALC)
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct c...
- Open
- 0.6599
- High
- 0.6887
- Low
- 0.6400
- Prev. Close
- 0.6573
- Volume
- 120.72K
- Turnover
- 79.97K
- Avg Price
- 0.6625
- Bid/Ask Ratio
- -88.68%
- Amplitude
- 7.41%
- 52wk High
- 7.2000
- Volume Ratio
- 0.45
- Turnover Ratio
- 7.82%
CalciMedica Analyst Rating
View moreForecast & Rating
Aug 12, 2026Price forecast
$10.501455.33%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- Earnings Watch · Aug 11 at 06:16 AM
CalciMedica | 8-K: FY2026 Q2 Revenue: USD 0
- Global Report · Aug 4 at 04:17 AM
Mid-Cap and Niche Sector Operators Report Strong 2026 Growth Amid Broadening Market Rally
- benzinga_article · Aug 3 at 12:05 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga_article · Jul 28 at 04:06 PM
12 Health Care Stocks Moving In Tuesday's After-Market Session
- PUBT · Jul 13 at 04:00 PM
CalciMedica announces annual shareholder meeting
- TradingView · Jul 10 at 04:36 PM
Alafi Capital Discloses Investment at CalciMedica with 17.1% Stake
